![]() |
|||||||||||||
|
All | Since 2019 | |
Citation | 5450 | 3969 |
h-index | 23 | 20 |
i10-index | 134 | 84 |
AN OVERVIEW ON DEVELOPED AND VALIDATED METHODS FOR METFORMIN AND GLIBENCLAMIDE IN BULK AND COMBINED DOSAGE FORMS
G. Maggi Stella*, K. Geetha*, A. Ajitha and V. Uma Maheswara Rao
ABSTRACT Metformin hydrochloride is the biguanide class of oral antihyperglycemics improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. It is developed and validated by different instruments like UV-Spectroscopy, HPLC and RP-HPLC. Glibenclamide also known as glyburide is a potent, second generation oral sulfonylurea antidiabetic agent widely used to lower blood glucose levels in patients with type II non-insulin-dependent diabetes mellitus. It is developed and validated by different instruments like UV Spectrophotometry and RP-HPLC. Metformin/glibenclamide (Glucovance) fixed-dose combination tablets are a second-line drug treatment for type 2 diabetes mellitus when glycaemic control does not improve with metformin or sulfonylurea monotherapy. It is developed and validated by different instruments like UV-Visible spectroscopy, RP-HPLC and HPTLC. The developed methods were accurate, precise and linear. Keywords: Metformin, Glibenclamide, Glucovance, UV-Spectroscopy, HPLC, RP-HPLC, HPTLC. [Download Article] [Download Certifiate] |